Rasagiline
- Product NDC
- 42291-779
- 11-digit product format
- 422910779
- Labeler code
- 42291
- Product ID
- 42291-779_ec19a5c9-a071-4082-e053-2995a90aba71
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rasagiline
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvKARE
- Application
- NDA021641
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2021-05-20
- Marketing end
- 0000-00-00
- Substance
- RASAGILINE MESYLATE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42291-779 | RASAGILINE TABLET [AVKARE] | 3 | Legacy NDC | 20231108_c2c8a281-065a-faf5-e053-2995a90aa13f.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-779-30 | 42291077930 | 30 TABLET in 1 BOTTLE (42291-779-30) | 30 tablet | 2021-05-20 | 0000-00-00 | No | No | Current |